Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™
PAOLI, PA — Sedor Pharmaceuticals, LLC (Sedor) recently announced that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT (fosphenytoin sodium for injection) for the treatment of status epilepticus in …
Read More